Literature DB >> 21550396

Upgrading molecular diagnostics of myotonic dystrophies: multiplexing for simultaneous characterization of the DMPK and ZNF9 repeat motifs.

Jan Radvansky1, Andrej Ficek, Ludevit Kadasi.   

Abstract

Myotonic dystrophy (DM) is a common neuromuscular disorder comprising at least two genetically different forms. DM1 is caused by expansion of a (CTG)(n) repeat in the DMPK gene, while DM2 is caused by expansion of a (CCTG)(n) part of a complex repetitive motif (TG)(n)(TCTG)(n)(CCTG)(n) in the ZNF9 gene. Detection of the responsible expansions is complicated in both cases because of the extremely variable length of the expanded alleles, which can contain even several thousands of repeats in both disorders. One of the commonly used detection approaches utilizes the combination of conventional PCR and "triplet" or "tetraplet" repeat-primed PCR (TP-PCR). TP-PCR can be performed simultaneously or successively in both DM1 and DM2 testing. We have designed two multiplex reactions which include bi-directionally labelled conventional PCRs and TP-PCRs for both DM1 and DM2 loci. These two reactions can be used under the same amplification and electrophoretic conditions thus allowing their parallelisation into a one step method. Simultaneous analysis of the samples using these two multiplex reactions allows characterization of both the DM1 and DM2 repeat regions in the time usually required for the first screening step in conventional DM1 or DM2 testing.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550396     DOI: 10.1016/j.mcp.2011.04.006

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  11 in total

Review 1.  Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes.

Authors:  Kevin Yum; Eric T Wang; Auinash Kalsotra
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

2.  Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions.

Authors:  Jovan Pešović; S Perić; M Brkušanin; G Brajušković; V Rakočević-Stojanović; Dušanka Savić-Pavićević
Journal:  Neurogenetics       Date:  2017-09-23       Impact factor: 2.660

3.  Transparency of reporting in molecular diagnostics.

Authors:  Stephen Bustin
Journal:  Int J Mol Sci       Date:  2013-07-30       Impact factor: 5.923

4.  Assessment of Premutation in Myotonic Dystrophy Type 1 Affected Family Members by TP-PCR and Genetic Counseling.

Authors:  Ashok Kumar; Sarita Agarwal; Sunil Pradhan
Journal:  Case Rep Med       Date:  2014-02-23

5.  Application of a reliable and rapid polymerase chain reaction based method in the diagnosis of myotonic dystrophy type 1 (DM1) in India.

Authors:  Ashok Kumar; Sarita Agarwal; Shubha R Phadke; Sunil Pradhan
Journal:  Meta Gene       Date:  2014-01-15

6.  The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.

Authors:  Alfonsina Ballester-Lopez; Ian Linares-Pardo; Emma Koehorst; Judit Núñez-Manchón; Guillem Pintos-Morell; Jaume Coll-Cantí; Miriam Almendrote; Giuseppe Lucente; Andrea Arbex; Jonathan J Magaña; Nadia M Murillo-Melo; Alejandro Lucia; Darren G Monckton; Sarah A Cumming; Alba Ramos-Fransi; Alicia Martínez-Piñeiro; Gisela Nogales-Gadea
Journal:  Genes (Basel)       Date:  2020-07-07       Impact factor: 4.096

7.  Metabolic impairments in patients with myotonic dystrophy type 2.

Authors:  Milorad Vujnic; Stojan Peric; Zeljka Calic; Natasa Benovic; Tanja Nisic; Jovan Pesovic; Dusanka Savic-Pavicevic; Vidosava Rakocevic-Stojanovic
Journal:  Acta Myol       Date:  2018-12-01

Review 8.  Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1.

Authors:  Stojan Peric; Jovan Pesovic; Dusanka Savic-Pavicevic; Vidosava Rakocevic Stojanovic; Giovanni Meola
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

Review 9.  Molecular genetics and genetic testing in myotonic dystrophy type 1.

Authors:  Dušanka Savić Pavićević; Jelena Miladinović; Miloš Brkušanin; Saša Šviković; Svetlana Djurica; Goran Brajušković; Stanka Romac
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

10.  Clinical and genetic analysis of the first known Asian family with myotonic dystrophy type 2.

Authors:  Takahiro Nakayama; Harumasa Nakamura; Yasushi Oya; Takashi Kimura; Ichiro Imahuku; Kinji Ohno; Ichizo Nishino; Koji Abe; Tohru Matsuura
Journal:  J Hum Genet       Date:  2014-01-16       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.